AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glynova-M1 Tablet Tablet SR

Prescription Icon
Prescription Required

Marketer

Tycoon Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glynova-M1 Tablet Tablet SR

DiaBeta-Duo SR tablets are an antidiabetic medication, a combination therapy for adult type 2 diabetes. This medication helps regulate blood glucose levels. DiaBeta-Duo SR should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue taking this medicine as prescribed, even if feeling well or experiencing controlled blood sugar. Discontinuing without medical consultation risks elevated blood glucose, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication is part of a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Commonly, DiaBeta-Duo SR may cause hypoglycemia (low blood sugar). Learn to recognize symptoms like sweating, lightheadedness, headache, and tremors, and know how to manage them. Regular meals and carrying a fast-acting glucose source (e.g., sugary snacks or juice) are crucial. Alcohol consumption increases hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. Do not use DiaBeta-Duo SR if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver impairment. Inform your doctor of any history of heart disease before starting treatment; it may be unsuitable. Pregnant or breastfeeding individuals should consult their doctor prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.

Uses of Glynova-M1 Tablet Tablet SR

Managing type 2 diabetes

Major Benefits of Glynova-M1 Tablet Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glynova-M1 Tablet SR with a meal.

Common Side effects of Glynova-M1 Tablet Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glynova-M1 Tablet Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glynova-M1 SR should be administered with a meal.

How Glynova-M1 Tablet Tablet SR works:

Glynova-M1 SR tablets combine glimepiride, a sulfonylurea, and metformin, a biguanide, to manage blood sugar. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Glynova-M1 SR tablets and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glynova-M1 SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Medical advice is recommended.

Breast feedingBreast feedingUNSAFE

Extended-release Glynova-M1 tablets are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glynova-M1 SR tablets cautiously, potentially requiring dose modification. Severe kidney disease contraindicates Glynova-M1 SR tablet use. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glynova-M1 SR tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. A reduced initial dose is typically recommended for individuals with mild to moderate liver disease; Glynova-M1 SR tablets are unsuitable for those with severe hepatic dysfunction.

What if you forget to take Glynova-M1 Tablet Tablet SR :

Should you forget a Glynova-M1 SR Tablet dose, take it immediately if you remember. However, near the time for your next scheduled dose, omit the missed one and resume your usual dosing pattern. Never take a double dose.

Facts to Know About Glynova-M1 Tablet Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Glynova-M1 Tablet Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glynova-M1 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glynova-M1 Tablet SR and seek immediate medical attention.
Glynova-M1 SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glynova-M1 SR is not suitable for type 1 diabetes.
Glynova-M1 SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glynova-M1 SR tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and gait instability), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended at least annually, according to some researchers.
Glynova-M1 SR Tablets can cause low blood sugar (hypoglycemia), with symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases if you skip meals, drink alcohol, over-exercise, or take other diabetes medication. Regular blood sugar monitoring is essential. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glynova-M1 SR tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glynova-M1 Tablet Tablet ...
60
MRP 69
13% off